5. Consolidation: Reshaping Pharmacy and Beyond

	There is a concern that mergers and acquisitions in the pharmacy space will lead to decreased competition and loose agreements between companies that will not drive significant outcomes. 

4. FDA Approves Second Biosimilar to Neupogen

	The FDA approved Pfizer's filgrastim-aafi, a filgrastim biosimilar to Amgen's Neupogen. 

3. Injection Drug Users Can Benefit from a Partially Effective Hepatitis C Vaccine

	Researchers estimated whether a hepatitis C vaccine could reduce transmission of the virus among injection drug users, even without providing complete immunity. 

2. FDA OKs New Drug for Endometriosis Pain Management

	Officials with the FDA have approved elagolix (Orilissa, AbbVie), a product specifically developed for women with moderate to severe endometriosis pain. 

1. Global Treatment Coverage of Hepatitis B Lagging

	Taking advantage of cost-effective generic medications can improve access to hepatitis B treatment, especially in countries with a high disease burden. 

News

Hepatitis

® Hepatitis Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of a group of distinct diseases that cause inflammation of the liver, including hepatitis A, B, C, and D.

Specialty Pharmacy

® Pharmacy Technician Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to specialty pharmacists.

Top news of the week from Specialty Pharmacy Times.

Global Disease Burden of Hepatitis B Tops SPT Week in Review